Why? Brew yourself a cup of tea, get comfortable in your recliner and begin reading at p.32 of 3M’s most recent quarterly report:
https://s24.q4cdn.com/834031268/files/doc_downloads/2022/10/10Q/Final-Q3-2022-10-Q.pdf
By the time you finish page 33, you should be envisioning of an army of highly paid, well-dressed lawyers across the globe shoveling heaping piles of 3M cash into a blast furnace. Surrounding these lawyers are entire groups of 3Mers, whose time is solely dedicated to managing the enterprise-level crisis, as opposed to productive business activities such as developing, manufacturing and selling products.
As you contemplate such a juicy acquisition target, with its seemingly unbounded liabilities (“the Company is not able to estimate a possible loss or range of possible loss at this time”), I recommend rounding out the pre-acquisition diligence by searching for any new updates in the (mere) intervening month since the 10-Q release. You’ll find things like this:
https://www.epa.gov/system/files/documents/2022-11/Final.signed.AOC%20SDWA%201431.3M%20Cordova%20IL.Nov_.%2003%202022_1.pdf
Or this:
https://www.wsj.com/articles/california-sues-3m-and-dupont-over-pfas-chemicals-11668113297
After the CERCLA designations for PFOA and PFOS come to pass, folks will reminisce about these times being good ones.
If you wouldn’t be willing to put in an offer on 3M Flurochemicals, a more sophisticated investor certainly won’t either. Highly unlikely that 3M will be able to unload this line of business.